BUMETANIDE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 6 adverse event reports in the FDA FAERS database where BUMETANIDE was used for Psoriasis.
Most Reported Side Effects for BUMETANIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 490 | 22.9% | 42 | 439 |
| Drug ineffective | 186 | 8.7% | 6 | 105 |
| Hypotension | 182 | 8.5% | 42 | 138 |
| Fatigue | 173 | 8.1% | 4 | 115 |
| Dehydration | 170 | 7.9% | 26 | 141 |
| Dyspnoea | 147 | 6.9% | 13 | 80 |
| Dizziness | 129 | 6.0% | 25 | 90 |
| Weight increased | 113 | 5.3% | 4 | 73 |
| Cardiac failure | 97 | 4.5% | 39 | 81 |
| Renal impairment | 89 | 4.2% | 14 | 50 |
| Hypokalaemia | 80 | 3.7% | 13 | 63 |
| Asthenia | 76 | 3.5% | 2 | 45 |
| Diarrhoea | 76 | 3.5% | 15 | 45 |
| Fall | 75 | 3.5% | 14 | 59 |
| Hyponatraemia | 75 | 3.5% | 2 | 71 |
Other Indications for BUMETANIDE
Product used for unknown indication (899)
Cardiac failure (212)
Cardiac failure congestive (97)
Hypertension (91)
Diuretic therapy (72)
Oedema (64)
Complex regional pain syndrome (63)
Fluid retention (49)
Hypervolaemia (25)
Oedema peripheral (25)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)